subject: UMLS:C3640223


subject: CHEBI:17026

subject_name: Progesterone

object_name: cannabis abuse

tested_intervention: unsure


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:5959

subject_name: Irbesartan

object_name: Ehlers-Danlos syndrome, vascular type

tested_intervention: yes


subject: CHEBI:5959

object_name: autosomal dominant Ehlers-Danlos syndrome, vascular type


subject: UMLS:C0879283

object_name: mantle cell lymphoma


subject: CHEBI:125628

subject_name: Alisertib

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:125628

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:125628

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:125628

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:125628

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:125628

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:125628

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:125628

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:125628

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:125628

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:125628

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:125628

object_name: anaplastic large cell lymphoma


subject: CHEBI:125628

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:125628

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:125628

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:125628

object_name: testicular lymphoma


subject: CHEBI:125628

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:125628

object_name: intraocular lymphoma


subject: CHEBI:125628

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:125628

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:125628

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:125628

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:125628

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:125628

object_name: small intestine lymphoma


subject: CHEBI:125628

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:125628

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:125628

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:125628

object_name: MALT lymphoma


subject: CHEBI:125628

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:125628

object_name: splenic marginal zone lymphoma


subject: CHEBI:125628

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:125628

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:125628

object_name: Lymphomatous Involvement of Non-Cutaneous Extranodal Site


subject: CHEBI:125628

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:125628

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:125628

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:125628

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:125628

object_name: refractory hairy cell leukemia


subject: CHEBI:125628

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:45716

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:45716

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:45716

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:45716

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:45716

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:45716

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:45716

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:45716

object_name: anaplastic large cell lymphoma


subject: CHEBI:45716

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:45716

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:45716

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:45716

object_name: testicular lymphoma


subject: CHEBI:45716

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:45716

object_name: intraocular lymphoma


subject: CHEBI:45716

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:45716

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:45716

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:45716

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:45716

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:45716

object_name: small intestine lymphoma


subject: CHEBI:45716

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:45716

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:45716

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:45716

object_name: MALT lymphoma


subject: CHEBI:45716

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:45716

object_name: splenic marginal zone lymphoma


subject: CHEBI:45716

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:45716

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:45716

object_name: Lymphomatous Involvement of Non-Cutaneous Extranodal Site


subject: CHEBI:45716

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:45716

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:45716

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:45716

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:45716

object_name: refractory hairy cell leukemia


subject: CHEBI:45716

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: HER2 positive


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:195558

subject_name: Entrectinib

object_name: Childhood Solid Neoplasm


subject: CHEBI:195558

object_name: Adult Solid Neoplasm


subject: CHEBI:195558

object_name: Solid Neoplasm


subject: PR:000016619

subject_name: trafficking protein particle complex subunit 9


subject: PR:000016619


subject: PR:000016619


subject: PR:000008994

subject_name: interleukin-1 receptor-like 1


subject: PR:000008994


subject: PR:000008994


subject: PR:000003595

subject_name: 3-ketoacyl-CoA thiolase, mitochondrial


subject: PR:000003595


subject: PR:000003595


subject: CHEBI:35430

subject_name: DIIODOTHYRONINE


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:29298

subject_name: ditritium


subject: CHEBI:29298


subject: CHEBI:29298


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: UniProtKB:Q06666

subject_name: T2_MOUSE Octapeptide-repeat protein T2 (sprot)


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: PR:000034234

subject_name: octapeptide-repeat protein T2


subject: PR:000034234


subject: PR:000034234


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: plasma cell myeloma


subject: CHEBI:74327

subject_name: Ile-Val


subject: UNII:R30772KCU0

subject_name: Isatuximab


subject: UMLS:C2983777


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:78140854

object_name: acute myeloid leukemia


subject: CHEBI:32599

object_name: perinatal asphyxia


subject: CHEBI:231425

subject_name: tolvaptan

object_name: HYPONATREMIA HYPOVOLEMIC


subject: UMLS:C5417912

subject_name: MEK 1/2 Inhibitor FCN-159

object_name: arteriovenous malformations of the brain


subject: CHEBI:50858

subject_name: corticosteroid

object_name: sarcoidosis


subject: CHEBI:50858

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:50858

object_name: pulmonary sarcoidosis


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: GTOPDB:6749

subject_name: fibrinogen

object_name: Intraoperative Complication


subject: GTOPDB:6749

object_name: lung disorder


subject: KEGG.COMPOUND:C00393

subject_name: Fibrinogen


subject: KEGG.COMPOUND:C00393


subject: UMLS:C3540039

subject_name: Fibrinogen containing hemostatics


subject: UMLS:C3540039


subject: UMLS:C2587184

subject_name: Parenogen


subject: UMLS:C2587184


subject: UMLS:C0016006


subject: UMLS:C0016006


subject: GTOPDB:4453

subject_name: thrombin


subject: GTOPDB:4453


subject: CHEBI:9574

subject_name: Thrombin


subject: CHEBI:9574


subject: UMLS:C1337342

subject_name: thrombin, bovine


subject: UMLS:C1337342


subject: UMLS:C0040018


subject: UMLS:C0040018


subject: UMLS:C1871272

subject_name: TachoSil


subject: UMLS:C1871272


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: autoimmune hemolytic anemia, warm type


subject: PUBCHEM.COMPOUND:163203529

subject_name: YIMITASVIR PHOSPHATE

object_name: Hepatic impairment


subject: UMLS:C4742120

subject_name: yimitasvir phosphate


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: diabetes mellitus type 2 with hyperglycemia


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Adult Penile Carcinoma


subject: UNII:KXG2PJ551I

object_name: penis carcinoma


subject: UNII:KXG2PJ551I

object_name: penile cancer


subject: UNII:KXG2PJ551I

object_name: squamous cell carcinoma of penis


subject: UNII:KXG2PJ551I

object_name: penile neoplasm


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:63624

subject_name: Telbivudine

object_name: Cirrhosis


subject: CHEBI:63624

object_name: liver cirrhosis


subject: CHEBI:86158

subject_name: calcium chloride dihydrate

object_name: Immediate Postpartum Hemorrhage


subject: CHEBI:3312

subject_name: Calol


subject: CHEBI:39112

subject_name: Bosutinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:39112

object_name: breast carcinoma


subject: CHEBI:39112

object_name: breast cancer


subject: UNII:3QW12I37H1

subject_name: SUROVATAMIG

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:3QW12I37H1

object_name: B-cell neoplasm


subject: UMLS:C5555141


subject: UMLS:C5555141


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic urothelial carcinoma


subject: CHEBI:231614

object_name: Urothelial carcinoma ureter metastatic


subject: CHEBI:231614

object_name: Metastatic Urethral Urothelial Carcinoma


subject: CHEBI:231614

object_name: Urothelial carcinoma recurrent


subject: CHEBI:231614

object_name: Metastatic Bladder Urothelial Carcinoma


subject: CHEBI:231614

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: CHEBI:231614

object_name: Unresectable Urothelial Carcinoma


subject: CHEBI:231614

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:231614

object_name: Urothelial carcinoma ureter recurrent


subject: CHEBI:231614

object_name: Urothelial carcinoma bladder recurrent


subject: CHEBI:231614

object_name: Urothelial carcinoma urethra recurrent


subject: CHEBI:231614

object_name: Unresectable Ureter Urothelial Carcinoma


subject: CHEBI:231614

object_name: Locally Advanced Ureter Urothelial Carcinoma


subject: CHEBI:231614

object_name: Recurrent Renal Pelvis Urothelial Carcinoma


subject: CHEBI:231614

object_name: Unresectable Bladder Urothelial Carcinoma


subject: CHEBI:231614

object_name: Locally Advanced Bladder Urothelial Carcinoma


subject: CHEBI:231614

object_name: Unresectable Urethral Urothelial Carcinoma


subject: CHEBI:231614

object_name: Locally Advanced Urethral Urothelial Carcinoma


subject: CHEBI:231614

object_name: Unresectable Renal Pelvis Urothelial Carcinoma


subject: CHEBI:231614

object_name: Locally Advanced Renal Pelvis Urothelial Carcinoma


subject: CHEBI:231614

object_name: Stage IV Urethral Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage III Urethral Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage III Ureter Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Ureter Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVB Bladder Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UMLS:C2346820

object_name: Metastatic urothelial carcinoma


subject: UMLS:C2346820

object_name: Urothelial carcinoma ureter metastatic


subject: UMLS:C2346820

object_name: Metastatic Urethral Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Urothelial carcinoma recurrent


subject: UMLS:C2346820

object_name: Metastatic Bladder Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Unresectable Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Locally Advanced Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Urothelial carcinoma ureter recurrent


subject: UMLS:C2346820

object_name: Urothelial carcinoma bladder recurrent


subject: UMLS:C2346820

object_name: Urothelial carcinoma urethra recurrent


subject: UMLS:C2346820

object_name: Unresectable Ureter Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Locally Advanced Ureter Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Renal Pelvis Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Unresectable Bladder Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Locally Advanced Bladder Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Unresectable Urethral Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Locally Advanced Urethral Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Unresectable Renal Pelvis Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Locally Advanced Renal Pelvis Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Stage IV Urethral Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage III Urethral Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage III Ureter Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Ureter Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVB Bladder Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Metastatic urothelial carcinoma


subject: UNII:AF75XOF6W3

object_name: Urothelial carcinoma ureter metastatic


subject: UNII:AF75XOF6W3

object_name: Metastatic Urethral Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Urothelial carcinoma recurrent


subject: UNII:AF75XOF6W3

object_name: Metastatic Bladder Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Unresectable Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Locally Advanced Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Urothelial carcinoma ureter recurrent


subject: UNII:AF75XOF6W3

object_name: Urothelial carcinoma bladder recurrent


subject: UNII:AF75XOF6W3

object_name: Urothelial carcinoma urethra recurrent


subject: UNII:AF75XOF6W3

object_name: Unresectable Ureter Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Locally Advanced Ureter Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Recurrent Renal Pelvis Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Unresectable Bladder Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Locally Advanced Bladder Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Unresectable Urethral Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Locally Advanced Urethral Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Unresectable Renal Pelvis Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Locally Advanced Renal Pelvis Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Stage IV Urethral Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage III Urethral Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage III Ureter Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage IV Ureter Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage III Bladder Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage IV Bladder Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage IVB Bladder Cancer AJCC v8


subject: UNII:AF75XOF6W3

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UMLS:C3827149

object_name: Metastatic urothelial carcinoma


subject: UMLS:C3827149

object_name: Urothelial carcinoma ureter metastatic


subject: UMLS:C3827149

object_name: Metastatic Urethral Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Urothelial carcinoma recurrent


subject: UMLS:C3827149

object_name: Metastatic Bladder Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Unresectable Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Locally Advanced Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Urothelial carcinoma ureter recurrent


subject: UMLS:C3827149

object_name: Urothelial carcinoma bladder recurrent


subject: UMLS:C3827149

object_name: Urothelial carcinoma urethra recurrent


subject: UMLS:C3827149

object_name: Unresectable Ureter Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Locally Advanced Ureter Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Recurrent Renal Pelvis Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Unresectable Bladder Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Locally Advanced Bladder Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Unresectable Urethral Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Locally Advanced Urethral Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Unresectable Renal Pelvis Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Locally Advanced Renal Pelvis Urothelial Carcinoma


subject: UMLS:C3827149

object_name: Stage IV Urethral Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage III Urethral Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage III Ureter Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage IV Ureter Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage IVB Bladder Cancer AJCC v8


subject: UMLS:C3827149

object_name: Stage IVA Bladder Cancer AJCC v8


subject: CHEBI:6775

subject_name: Mesalazine

object_name: irritable bowel syndrome


subject: CHEBI:9123

subject_name: Sertraline

object_name: Osteochondritis


subject: CHEBI:9123

object_name: Compulsion


subject: CHEBI:9123


subject: UMLS:C0388088

object_name: relapsing-remitting multiple sclerosis


subject: PUBCHEM.COMPOUND:10752953

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:10752953

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:10752953

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage IB Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:10752953

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage IA Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:10752953

object_name: stage IA breast cancer


subject: PUBCHEM.COMPOUND:10752953

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:50182

subject_name: ARUNDINE


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Neuropathic spinal arthropathy


subject: CHEBI:3215

object_name: intervertebral disk degenerative disorder


subject: CHEBI:3215

object_name: lumbar disk degenerative disorder


subject: CHEBI:3215

object_name: lumbar disc herniation


subject: CHEBI:3215

object_name: Lumbosacral radiculopathy


subject: CHEBI:3215

object_name: spondylolisthesis


subject: CHEBI:3215

object_name: Congenital spondylolisthesis


subject: CHEBI:3215

object_name: Acquired spondylolisthesis


subject: CHEBI:3215

object_name: spondylolysis


subject: CHEBI:3215

object_name: stricture


subject: CHEBI:180911

object_name: adrenal carcinoma


subject: CHEBI:180911

object_name: adrenal cortex carcinoma


subject: CHEBI:45906

subject_name: Suramin


subject: CHEBI:45906


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:28918

subject_name: Epinephrine

object_name: cardiac arrest


subject: CHEBI:28918

object_name: Cardiorespiratory arrest


subject: CHEBI:28918

object_name: Adrenalin causing adverse effects in therapeutic use


subject: UMLS:C4054906

subject_name: Gallium Ga 68-NOTA-AE105

object_name: prostate carcinoma


subject: UMLS:C4054906

object_name: prostate cancer


subject: CHEBI:6129

subject_name: Ketorolac

object_name: cataract


subject: CHEBI:6129

object_name: Cataract, CTCAE 3.0


subject: CHEBI:6129

object_name: Cataract, CTCAE 5.0


subject: CHEBI:6129

object_name: cataract on exam (physical finding)


subject: PUBCHEM.COMPOUND:4895

subject_name: Pred Forte


subject: PUBCHEM.COMPOUND:4895


subject: PUBCHEM.COMPOUND:4895


subject: PUBCHEM.COMPOUND:4895


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:2704

subject_name: Anastrozole

object_name: endometriosis


subject: CHEBI:231594

subject_name: Norgestrel


subject: UMLS:C0591582

subject_name: gyno-daktarin


subject: CHEBI:53774

subject_name: tergitol


subject: UMLS:C2718079

subject_name: Patentex Oval


subject: CHEBI:53775


subject: UNII:UG7I3Y42PV

subject_name: Fluoroazomycin arabinoside F-18

object_name: Pancreatic carcinoma non-resectable


subject: UNII:UG7I3Y42PV

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:UG7I3Y42PV


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: PR:000023317

object_name: rheumatoid arthritis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Childhood Breast Carcinoma


subject: CHEBI:4466

object_name: breast carcinoma


subject: CHEBI:4466

object_name: breast cancer


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:8364

subject_name: Prazosin

object_name: alcohol abuse


subject: CHEBI:8364

object_name: alcohol dependence


subject: CHEBI:135041

subject_name: phenbenzamine


subject: CHEBI:135041


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEBI:4046


subject: CHEBI:57694

object_name: sarcoidosis


subject: CHEBI:57694

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:142432

subject_name: Vericiguat

object_name: heart failure


subject: CHEBI:142432

object_name: Heart Failure, CTCAE


subject: CHEBI:64816

object_name: thyroid tumor


subject: CHEBI:64816

object_name: thyroid gland carcinoma


subject: CHEBI:64816

object_name: thyroid cancer


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:94782

subject_name: Cediranib

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:94782

object_name: Recurrent Glioblastoma


subject: UMLS:C4310225

object_name: insulinoma


subject: CHEBI:8452

subject_name: Proflavine

object_name: mouth neoplasm


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: osteoarthritis, knee


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Alzheimer disease


subject: UMLS:C0086333

subject_name: Gammagard


subject: UNII:M0Q7802G2B

subject_name: Benzodiazepines

object_name: Agitation


subject: UNII:M0Q7802G2B

object_name: acute disease


subject: UMLS:C4048284

subject_name: Benzodiazepine


subject: UMLS:C4048284


subject: UMLS:C3536850

subject_name: Benzodiazepine [EPC]


subject: UMLS:C3536850


subject: UMLS:C4058551

subject_name: Paliperidone ER


subject: UMLS:C4058551


subject: UMLS:C4085978

subject_name: Anti-pd-1 checkpoint inhibitor pf-06801591

object_name: hereditary fructose intolerance


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: liver carcinoma


subject: CHEBI:80287

subject_name: Thymosin alpha-1


subject: UMLS:C1960405

subject_name: Iodinated contrast media

object_name: Childhood Breast Carcinoma


subject: UMLS:C1960405

object_name: breast carcinoma


subject: UMLS:C1960405

object_name: breast cancer


subject: UMLS:C4085979

object_name: gastric adenocarcinoma


subject: MESH:C475022

subject_name: Inflexal V

object_name: influenza


subject: UNII:I7MVZ8HDNU

subject_name: Remibrutinib

object_name: Multiple sclerosis relapse


subject: UMLS:C5418043

subject_name: ADC SHR-A1811


subject: UMLS:C5418043


subject: UMLS:C5418043


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: UMLS:C2984507

subject_name: Poliorix

object_name: poliomyelitis


subject: CHEBI:2663

subject_name: Amiodarone

object_name: Postoperative Complications


subject: CHEBI:35674

subject_name: antihypertensive agent

object_name: Adverse effects


subject: CHEBI:35674

object_name: malignant hypertension


subject: CHEBI:35674

object_name: Hypertensive emergency


subject: CHEBI:35674

object_name: Hypertensive crisis


subject: CHEBI:35674

object_name: Hypoxemic Respiratory Failure


subject: UMLS:C0003364

subject_name: Antihypertensive Agents


subject: UMLS:C0003364


subject: UMLS:C0003364


subject: UMLS:C0003364


subject: UMLS:C0003364


subject: UMLS:C4724842

subject_name: Oral Moisturizing Jelly

object_name: head and neck cancer


subject: UMLS:C4724842

object_name: Xerostomia caused by ionizing radiation


subject: UMLS:C4724842

object_name: Xerostomia


subject: UMLS:C4724842

object_name: Dry Mouth, CTCAE


subject: CHEBI:95341

subject_name: Baricitinib


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Postmenopausal


subject: CHEBI:31355

subject_name: Carboplatin

object_name: small cell lung carcinoma


subject: CHEBI:31905

subject_name: Nicorandil

object_name: coronary artery disorder


subject: CHEBI:31905

object_name: coronary atherosclerosis


subject: CHEBI:10023

subject_name: Voriconazole

object_name: corneal ulcer


subject: CHEBI:10023

object_name: Corneal Ulcer, CTCAE


subject: CHEBI:10023

object_name: fungal infection of eye


subject: UNII:R3I80TLN7S

subject_name: Milademetan

object_name: adult lymphoma


subject: UNII:R3I80TLN7S

object_name: lymphoma


subject: UNII:R3I80TLN7S

object_name: pediatric lymphoma


subject: UNII:R3I80TLN7S

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4279258

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4279258

object_name: chronic leukemia


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: circadian rhythm sleep disorder, delayed sleep phase type


subject: UMLS:C3864309

subject_name: PAPILLOMAVIRUS HUMAN 9-VALENT VACCINE

object_name: Oral infection


subject: UMLS:C3864309

object_name: Disease due to Papillomaviridae


subject: UMLS:C3864309

object_name: human papilloma virus infection


subject: UMLS:C3864309

object_name: cervical intraepithelial neoplasia


subject: UMLS:C3864309

object_name: dysplasia of cervix


subject: UMLS:C3864309

object_name: HIV infection


subject: UMLS:C3864309

object_name: Anal intraepithelial neoplasia


subject: CHEBI:231679

subject_name: ipilimumab

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:231679

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:231679

object_name: Resectable Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:231679

object_name: dedifferentiated liposarcoma


subject: CHEBI:231679

object_name: Malignant fibrous histiocytoma recurrent


subject: CHEBI:231679

object_name: Resectable Dedifferentiated Liposarcoma


subject: CHEBI:231679

object_name: Recurrent Dedifferentiated Liposarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: nasopharyngeal neoplasm


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: myeloid leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:6801

subject_name: Metformin

object_name: hyperglycemia


subject: CHEBI:6801

object_name: Hyperglycemia, CTCAE


subject: CHEBI:6801

object_name: Glucose in blood specimen above reference range


subject: CHEBI:6801


subject: CHEBI:9014

subject_name: Salsalate


subject: CHEBI:9014


subject: CHEBI:9014


subject: CHEBI:9014


subject: CHEBI:9014

object_name: type 2 diabetes mellitus


subject: UMLS:C5417823

object_name: autoimmune hemolytic anemia, warm type


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Primary mediastinal large B-cell lymphoma (PMBCL)


subject: UNII:D6OMY2L0WA

object_name: mantle cell lymphoma


subject: UNII:D6OMY2L0WA

object_name: mast cell leukemia


subject: UNII:D6OMY2L0WA

object_name: Multiple cutaneous leiomyomas


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: CHEBI:62466

subject_name: Prolycopene

object_name: Periodontal Pocket


subject: CHEBI:15948

subject_name: Lycopene


subject: UNII:7E99B9ZM19


subject: CHEBI:31205

subject_name: Amlexanox

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:31205

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:31205

object_name: obesity


subject: CHEBI:31205

object_name: Obesity, CTCAE


subject: CHEBI:31205


subject: CHEBI:31205

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:50693

subject_name: Milrinone

object_name: heart valve disorder


subject: CHEBI:50693

object_name: Valvular Heart Disease, CTCAE


subject: CHEBI:50693

object_name: myocardial ischemia


subject: CHEBI:50693

object_name: Family history of ischemic heart disease


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Immune defect


subject: CHEBI:89324

object_name: Premature infant


subject: CHEBI:89324

object_name: Premature birth


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C5449291

subject_name: soybean, fermented

object_name: pulmonary tuberculosis


subject: UMLS:C5449291

object_name: Weight Change


subject: PUBCHEM.COMPOUND:544190

object_name: Pregnant


subject: CHEBI:7798

subject_name: Oseltamivir


subject: UNII:Y4HRG433UU

subject_name: Tedisamil Sesquifumarate

object_name: atrial fibrillation


subject: UNII:Y4HRG433UU

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:Y4HRG433UU

object_name: Atrial Fibrillation, CTCAE


subject: UNII:Y4HRG433UU

object_name: atrial flutter


subject: UNII:Y4HRG433UU

object_name: Atrial Flutter by ECG Finding


subject: UNII:Y4HRG433UU

object_name: Atrial Flutter, CTCAE


subject: UMLS:C2348658


subject: UMLS:C2348658


subject: UMLS:C2348658


subject: UMLS:C2348658


subject: UMLS:C2348658


subject: UMLS:C2348658


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: atopic eczema


subject: CHEBI:60648

object_name: dermatitis


subject: CHEBI:60648

object_name: Eczema, CTCAE


subject: CHEBI:60648

object_name: Dermatitis


subject: CHEBI:60648

object_name: skin disorder


subject: CHEBI:60648

object_name: Genodermatosis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:133246

subject_name: Ligustrazine


subject: CHEBI:133246


subject: CHEBI:133246


subject: CHEBI:133246


subject: CHEBI:133246


subject: CHEBI:133246


subject: CHEBI:45394

subject_name: TMP


subject: CHEBI:45394


subject: CHEBI:45394


subject: CHEBI:45394


subject: CHEBI:45394


subject: CHEBI:45394


subject: CHEBI:46324

subject_name: trimethyl phosphate


subject: CHEBI:46324


subject: CHEBI:46324


subject: CHEBI:46324


subject: CHEBI:46324


subject: CHEBI:46324


subject: CHEBI:9533

subject_name: thiamine(1+) monophosphate


subject: CHEBI:9533


subject: CHEBI:9533


subject: CHEBI:9533


subject: CHEBI:9533


subject: CHEBI:9533


subject: CHEBI:17013

subject_name: dTMP


subject: CHEBI:17013


subject: CHEBI:17013


subject: CHEBI:17013


subject: CHEBI:17013


subject: CHEBI:17013


subject: CHEBI:63528


subject: CHEBI:63528


subject: CHEBI:63528


subject: CHEBI:63528


subject: CHEBI:63528


subject: CHEBI:63528


subject: UMLS:C0384479

subject_name: epithelial membrane protein-1


subject: UMLS:C0384479


subject: UMLS:C0384479


subject: UMLS:C0384479


subject: UMLS:C0384479


subject: UMLS:C0384479


subject: PR:000007062

subject_name: epithelial membrane protein 1


subject: PR:000007062


subject: PR:000007062


subject: PR:000007062


subject: PR:000007062


subject: PR:000007062


subject: UniProtKB:P36590

subject_name: KTHY_SCHPO Thymidylate kinase (sprot)


subject: UniProtKB:P36590


subject: UniProtKB:P36590


subject: UniProtKB:P36590


subject: UniProtKB:P36590


subject: UniProtKB:P36590


subject: CHEBI:102265

subject_name: Sulfamethazine


subject: CHEBI:102265


subject: CHEBI:102265


subject: CHEBI:102265


subject: CHEBI:102265


subject: CHEBI:102265


subject: CHEBI:6121

subject_name: Ketamine

object_name: Laceration


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: osteoarthritis, knee


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249

object_name: asthma


subject: CHEBI:4856

subject_name: Esmolol


subject: CHEBI:4856


subject: CHEBI:4856


subject: UNII:GZ1X96601Z

subject_name: Tecadenoson


subject: UNII:GZ1X96601Z


subject: UNII:GZ1X96601Z


subject: UMLS:C0009906

subject_name: Combined Oral Contraceptives

object_name: Abnormal uterine bleeding


subject: UNII:L1F3R18W77

subject_name: Asciminib

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:4911

subject_name: Etoposide

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:156963498

subject_name: Mecapegfilgrastim

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:156963498

object_name: lymphoma


subject: PUBCHEM.COMPOUND:156963498

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:156963498


subject: UNII:I4QL0KKG3K

subject_name: pegylated granulocyte colony-stimulating factor


subject: UNII:I4QL0KKG3K


subject: UNII:I4QL0KKG3K


subject: UNII:I4QL0KKG3K


subject: CHEMBL.COMPOUND:CHEMBL5095279

subject_name: MECAPEGFILGRASTIM


subject: CHEMBL.COMPOUND:CHEMBL5095279


subject: CHEMBL.COMPOUND:CHEMBL5095279


subject: CHEMBL.COMPOUND:CHEMBL5095279


subject: UMLS:C3179328


subject: UMLS:C3179328


subject: UMLS:C3179328


subject: UMLS:C3179328


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: hepatic veno-occlusive disease


subject: UMLS:C5400018

object_name: Venous occlusion


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: UNII:438HCF2X0M


subject: UMLS:C5854431

subject_name: Anti-FAP Antibody-drug Conjugate OMTX705

object_name: Advanced Malignant Solid Neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UNII:35A26E427H

subject_name: Reslizumab

object_name: eosinophilic esophagitis


subject: UNII:35A26E427H

object_name: Eosinophilic infiltration of the esophagus


subject: PUBCHEM.COMPOUND:66811198

subject_name: SIMEPREVIR

object_name: chronic hepatitis C virus infection


subject: UNII:LH78JQC1MP

subject_name: Fermagate

object_name: chronic kidney disease


subject: UNII:LH78JQC1MP

object_name: Chronic uremia


subject: CHEBI:45783

subject_name: Imatinib

object_name: prostate carcinoma


subject: CHEBI:45783

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:66624888

subject_name: Remodulin

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:66624888

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:567361

subject_name: Cladribine

object_name: Refractory acute myeloid leukemia


subject: CHEBI:567361

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:567361

object_name: Refractory High Risk Myelodysplastic Syndrome


subject: CHEBI:567361

object_name: Recurrent High Risk Myelodysplastic Syndrome


subject: CHEBI:567361

object_name: acute biphenotypic leukemia in relapse


subject: CHEBI:567361

object_name: Blasts 20 Percent or More of Bone Marrow Nucleated Cells


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:90217

subject_name: Quizartinib


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:125427

object_name: diabetic kidney disease


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:2030

subject_name: orazamide

object_name: asthma


subject: CHEBI:2030

object_name: Allergy


subject: CHEBI:2030

object_name: History of allergies


subject: CHEBI:2030

object_name: Hay fever


subject: CHEBI:2030

object_name: Atopic rhinitis


subject: CHEBI:2030

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: lower urinary tract symptom


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: Acne inversa


subject: CHEBI:85990

subject_name: Panobinostat

object_name: melanoma


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2346454


subject: CHEBI:41423

subject_name: Celecoxib

object_name: liver cancer


subject: CHEBI:41423

object_name: liver neoplasm


subject: CHEBI:41423

object_name: Adult Liver Carcinoma


subject: UNII:EB87433V6F

object_name: Post-Operative Pain


subject: UNII:EB87433V6F


subject: UNII:EB87433V6F


subject: UNII:EB87433V6F


subject: UNII:EB87433V6F

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:21982135


subject: PUBCHEM.COMPOUND:21982135


subject: PUBCHEM.COMPOUND:21982135


subject: PUBCHEM.COMPOUND:21982135


subject: CHEBI:73038

subject_name: Parecoxib


subject: CHEBI:73038


subject: CHEBI:73038


subject: CHEBI:73038


subject: UMLS:C0723176

subject_name: SFC (Brand Name)


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:67357

subject_name: Dolastatin 10


subject: CHEBI:67357


subject: CHEBI:67357


subject: CHEBI:67357


subject: CHEBI:67357

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:67357

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:67357

object_name: gallbladder cancer


subject: CHEBI:67357

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:67357

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:67357

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:67357

object_name: gallbladder carcinoma


subject: CHEBI:67357

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:67357

object_name: malignant tumor of extrahepatic bile duct


subject: UMLS:C0082338

subject_name: dolastatin 10


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: epilepsy


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:50858

subject_name: corticosteroid

object_name: temporomandibular joint dysfunction syndrome


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: PUBCHEM.COMPOUND:3962

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:3962

object_name: atherosclerosis


subject: PUBCHEM.COMPOUND:3962

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:3962

object_name: coronary atherosclerosis


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: Chronic small plaque psoriasis


subject: UNII:BTY153760O

object_name: psoriatic arthritis


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Optic Nerve Injuries


subject: UMLS:C3713323

object_name: psoriasis


subject: CHEBI:16296

subject_name: D-Tryptophan

object_name: cocaine abuse


subject: CHEBI:27897

subject_name: tryptophan


subject: PUBCHEM.COMPOUND:21865528

object_name: Aspirin exacerbated respiratory disease


subject: CHEBI:188730

subject_name: Ifetroban


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: eosinophilic esophagitis


subject: UNII:420K487FSG

object_name: Eosinophilic infiltration of the esophagus


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:5134


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:28939

object_name: COPD, severe early onset


subject: CHEBI:28939

object_name: chronic obstructive pulmonary disease


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: Withdrawal Symptoms


subject: UNII:S4M959U2IJ

subject_name: Teplizumab

object_name: High risk of


subject: UNII:S4M959U2IJ

object_name: High risk


subject: UNII:S4M959U2IJ

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: UNII:S4M959U2IJ

object_name: High Risk Acute Leukemia


subject: UNII:S4M959U2IJ

object_name: International Prognostic Index High Risk Group


subject: UNII:S4M959U2IJ

object_name: Autoantibody positive


subject: UNII:S4M959U2IJ

object_name: Prediabetes


subject: UNII:S4M959U2IJ

object_name: glucose intolerance


subject: UNII:S4M959U2IJ

object_name: Impaired glucose tolerance


subject: UNII:IZY9ZSI6FI

subject_name: ZILOVERTAMAB VEDOTIN

object_name: diffuse large B-cell lymphoma


subject: UNII:IZY9ZSI6FI

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:IZY9ZSI6FI

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: CHEBI:3757

subject_name: Clonidine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:3757

object_name: obesity


subject: CHEBI:3757

object_name: Obesity, CTCAE


subject: CHEBI:3757

object_name: Diuretic adverse reaction


subject: CHEBI:3757

object_name: Blood Pressure Finding


subject: CHEBI:3757

object_name: Systemic arterial pressure


subject: CHEBI:3757

object_name: type 2 diabetes mellitus


subject: CHEBI:3757

object_name: Insulin resistance


subject: CHEBI:3757

object_name: Diabetes


subject: CHEBI:3757

object_name: diabetes mellitus


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:5778


subject: PUBCHEM.COMPOUND:138376495

subject_name: Cefiderocol

object_name: ventilator-associated pneumonia


subject: PUBCHEM.COMPOUND:138376495

object_name: Hospital acquired pneumonia


subject: CHEBI:10125

subject_name: Zolpidem

object_name: Cirrhosis


subject: CHEBI:10125

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Female infertility due to diminished ovarian reserve


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:68554

subject_name: Deferiprone

object_name: acute kidney failure


subject: CHEBI:68554

object_name: Acute Kidney Injury, CTCAE


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: headache migraine chronic


subject: PUBCHEM.COMPOUND:521372

object_name: Medication overuse headache


subject: PUBCHEM.COMPOUND:521372

object_name: Analgesic Overuse Headache


subject: CHEBI:69477

subject_name: Cannabigerol


subject: CHEBI:69477


subject: CHEBI:69477


subject: CHEBI:64354

subject_name: Metolazone

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:64354

object_name: Acute heart failure


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: non-small cell lung carcinoma


subject: CHEBI:38940

subject_name: Sunitinib

object_name: glioblastoma


subject: CHEBI:38940

object_name: Brain Stem Glioblastoma


subject: CHEBI:38940

object_name: glioma susceptibility 1


subject: CHEBI:32035

subject_name: Potassium hydroxide

object_name: molluscum contagiosum


subject: UMLS:C1095887

subject_name: broccoli preparation

object_name: dermatitis


subject: UMLS:C1095887

object_name: Dermatitis


subject: DRUGBANK:DB10511

subject_name: Broccoli


subject: DRUGBANK:DB10511


subject: UMLS:C1446658

subject_name: Mustard antigen


subject: UMLS:C1446658


subject: CHEBI:28925

subject_name: Mechlorethamine


subject: CHEBI:28925


subject: UMLS:C1095909

subject_name: Mustard preparation


subject: UMLS:C1095909


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:15365

subject_name: Aspirin

object_name: Hibernation, Myocardial


subject: CHEBI:15365

object_name: Complete occlusion of coronary artery


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:68558


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:39548


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: UMLS:C0591175

subject_name: Betaloc


subject: UMLS:C0591175


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: PUBCHEM.COMPOUND:42615

subject_name: BUSERELIN

object_name: Encounter due to In vitro fertilization


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: adult germ cell tumor


subject: CHEBI:72317

object_name: germ cell tumor


subject: CHEBI:72317

object_name: childhood germ cell tumor


subject: CHEBI:72317

object_name: Germ Cell Cancer


subject: CHEBI:72317

object_name: ovarian germ cell tumor


subject: CHEBI:72317

object_name: pediatric ovarian germ cell tumor


subject: CHEBI:72317

object_name: nongerminomatous germ cell tumor


subject: CHEBI:72317

object_name: seminoma


subject: CHEBI:72317

object_name: testicular germ cell tumor


subject: CHEBI:72317

object_name: testis seminoma


subject: CHEBI:601027

subject_name: Aliskiren

object_name: heart failure


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: peritoneum cancer


subject: PUBCHEM.COMPOUND:135423438

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:135423438

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:135423438

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: fallopian tube carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: fallopian tube cancer


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: UMLS:C1879771


subject: UMLS:C1879771


subject: UMLS:C1879771


subject: UMLS:C1879771


subject: UMLS:C1879771


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:4887

subject_name: Ethosuximide

object_name: migraine


subject: DRUGBANK:DB16636

subject_name: Gastrodia elata whole

object_name: hypertension


subject: DRUGBANK:DB16636

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:78122784

subject_name: Tenapanor

object_name: Finding of lactation


subject: UNII:6MC93Z2DF9

subject_name: Epetraborole

object_name: kidney failure


subject: UMLS:C3714179

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:231342

subject_name: ceralasertib


subject: CHEBI:231342


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Postoperative retention of urine


subject: CHEBI:52717

subject_name: Bortezomib

object_name: prostate cancer


subject: CHEBI:52717

object_name: prostate neoplasm


subject: UMLS:C5555135

subject_name: KRAS G12C Inhibitor D-1553

object_name: non-small cell lung carcinoma


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Compulsion


subject: CHEBI:93274

subject_name: Fluvoxamine


subject: CHEBI:73611

subject_name: Met-Gly


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: CHEBI:9943

subject_name: Venlafaxine


subject: PUBCHEM.COMPOUND:521267

subject_name: (R)-Carvotanacetone

object_name: periodontal disorder


subject: CHEBI:50742

subject_name: cyproterone


subject: CHEBI:44915

subject_name: Propofol

object_name: treatment resistant depression


subject: CHEBI:44915


subject: CHEBI:35778

subject_name: gadopentetate

object_name: malignant glioma


subject: CHEBI:31797

subject_name: Gadolinium DTPA


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: substance-related disorder


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: generalized anxiety disorder


subject: CHEBI:40279

subject_name: Allopurinol

object_name: acute myeloid leukemia


subject: CHEBI:176724

subject_name: Etiracetam


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: MESH:D000077324

subject_name: Crystalloid Solutions

object_name: At risk of infection


subject: MESH:D000077324

object_name: infectious disease


subject: UMLS:C0056562

subject_name: crystalloid solutions


subject: UMLS:C0056562


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: PUBCHEM.COMPOUND:74030550


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: stroke disorder


subject: CHEBI:44423

object_name: cerebrovascular disorder


subject: CHEBI:44423

object_name: Stroke (heart beat)


subject: CHEBI:44423

object_name: Stroke, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4594470

object_name: Childhood Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594470

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594470

object_name: Solid Neoplasm


subject: UMLS:C3896789


subject: UMLS:C3896789


subject: UMLS:C3896789


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Androgen excess


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB

object_name: diffuse large B-cell lymphoma


subject: UNII:7K5O7P6QIU

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:7K5O7P6QIU

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:7K5O7P6QIU

object_name: high grade B-cell lymphoma


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: systemic sclerosis


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:232328

object_name: acute myeloid leukemia


subject: CHEBI:232328

object_name: Myelodysplasia


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: systemic primary carnitine deficiency disease


subject: CHEBI:16347

object_name: Decreased circulating carnitine concentration


subject: CHEBI:16347

object_name: neurodevelopmental disorder


subject: CHEBI:16347

object_name: Premature infant


subject: CHEBI:16347

object_name: Premature birth


subject: UMLS:C2985186

object_name: focal segmental glomerulosclerosis


subject: UMLS:C4281781

subject_name: Bacillus subtilis antigen

object_name: Pneumonia caused by SARS-CoV-2


subject: DRUGBANK:DB11347

subject_name: Bacillus subtilis


subject: UMLS:C0939905

subject_name: oats preparation

object_name: ulcerative colitis


subject: UMLS:C0939905

object_name: inflammatory bowel disease 1


subject: DRUGBANK:DB10546

subject_name: Oat


subject: DRUGBANK:DB10546


subject: UMLS:C0000530

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:6121

subject_name: Ketamine

object_name: Nose Deformities, Acquired


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:29958

subject_name: L-aspartic acid residue


subject: CHEBI:22660

subject_name: aspartic acid


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Incipient Schizophrenia


subject: MESH:C078788

subject_name: ALVAC vaccine

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Ovarian cancer stage IV


subject: MESH:C078788

object_name: stage IIIC primary peritoneal cavity cancer


subject: MESH:C078788

object_name: stage IIIA primary peritoneal cavity cancer


subject: MESH:C078788

object_name: stage IIIB primary peritoneal cavity cancer


subject: MESH:C078788

object_name: stage IIA primary peritoneal cavity cancer


subject: MESH:C078788

object_name: stage IIB primary peritoneal cavity cancer


subject: MESH:C078788

object_name: stage IV primary peritoneal cavity cancer


subject: MESH:C078788

object_name: FIGO Stage IIIC Ovarian Cancer


subject: MESH:C078788

object_name: Stage IIIC Ovarian Cancer


subject: MESH:C078788

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: FIGO Stage IIIA Ovarian Cancer


subject: MESH:C078788

object_name: stage IIIB ovarian epithelial cancer


subject: MESH:C078788

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: recurrent primary peritoneal cavity cancer


subject: MESH:C078788

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: stage IIB ovarian epithelial cancer


subject: MESH:C078788

object_name: stage IIA ovarian epithelial cancer


subject: MESH:C078788

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: MESH:C078788

object_name: Recurrent ovarian cancer


subject: MESH:C078788

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: MESH:C078788

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: MESH:C078788

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: MESH:C078788

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: Recurrent Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Ovarian cancer stage IV


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IIIC primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IIIA primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IIIB primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IIA primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IIB primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IV primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: FIGO Stage IIIC Ovarian Cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIC Ovarian Cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: FIGO Stage IIIA Ovarian Cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IIIB ovarian epithelial cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: recurrent primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IIB ovarian epithelial cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: stage IIA ovarian epithelial cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:146014907

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:146014907

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Ovarian cancer stage IV


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IIIC primary peritoneal cavity cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IIIA primary peritoneal cavity cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IIIB primary peritoneal cavity cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IIA primary peritoneal cavity cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IIB primary peritoneal cavity cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IV primary peritoneal cavity cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: FIGO Stage IIIC Ovarian Cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIC Ovarian Cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: FIGO Stage IIIA Ovarian Cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IIIB ovarian epithelial cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: recurrent primary peritoneal cavity cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IIB ovarian epithelial cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: stage IIA ovarian epithelial cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Recurrent ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594483

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C4329606

subject_name: CTAG1 Antibody

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: Ovarian cancer stage IV


subject: UMLS:C4329606

object_name: stage IIIC primary peritoneal cavity cancer


subject: UMLS:C4329606

object_name: stage IIIA primary peritoneal cavity cancer


subject: UMLS:C4329606

object_name: stage IIIB primary peritoneal cavity cancer


subject: UMLS:C4329606

object_name: stage IIA primary peritoneal cavity cancer


subject: UMLS:C4329606

object_name: stage IIB primary peritoneal cavity cancer


subject: UMLS:C4329606

object_name: stage IV primary peritoneal cavity cancer


subject: UMLS:C4329606

object_name: FIGO Stage IIIC Ovarian Cancer


subject: UMLS:C4329606

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C4329606

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: FIGO Stage IIIA Ovarian Cancer


subject: UMLS:C4329606

object_name: stage IIIB ovarian epithelial cancer


subject: UMLS:C4329606

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: recurrent primary peritoneal cavity cancer


subject: UMLS:C4329606

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: stage IIB ovarian epithelial cancer


subject: UMLS:C4329606

object_name: stage IIA ovarian epithelial cancer


subject: UMLS:C4329606

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UMLS:C4329606

object_name: Recurrent ovarian cancer


subject: UMLS:C4329606

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C4329606

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C4329606

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C4329606

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C4329606

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C4329606

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C4329606

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C4329606

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C4329606

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C4329606

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C4329606

object_name: Recurrent Fallopian Tube Carcinoma


subject: UniProtKB:P78358

subject_name: CTG1B_HUMAN Cancer/testis antigen 1 (sprot)

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: Ovarian cancer stage IV


subject: UniProtKB:P78358

object_name: stage IIIC primary peritoneal cavity cancer


subject: UniProtKB:P78358

object_name: stage IIIA primary peritoneal cavity cancer


subject: UniProtKB:P78358

object_name: stage IIIB primary peritoneal cavity cancer


subject: UniProtKB:P78358

object_name: stage IIA primary peritoneal cavity cancer


subject: UniProtKB:P78358

object_name: stage IIB primary peritoneal cavity cancer


subject: UniProtKB:P78358

object_name: stage IV primary peritoneal cavity cancer


subject: UniProtKB:P78358

object_name: FIGO Stage IIIC Ovarian Cancer


subject: UniProtKB:P78358

object_name: Stage IIIC Ovarian Cancer


subject: UniProtKB:P78358

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: FIGO Stage IIIA Ovarian Cancer


subject: UniProtKB:P78358

object_name: stage IIIB ovarian epithelial cancer


subject: UniProtKB:P78358

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: recurrent primary peritoneal cavity cancer


subject: UniProtKB:P78358

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: stage IIB ovarian epithelial cancer


subject: UniProtKB:P78358

object_name: stage IIA ovarian epithelial cancer


subject: UniProtKB:P78358

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UniProtKB:P78358

object_name: Recurrent ovarian cancer


subject: UniProtKB:P78358

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UniProtKB:P78358

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UniProtKB:P78358

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UniProtKB:P78358

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UniProtKB:P78358

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UniProtKB:P78358

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UniProtKB:P78358

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UniProtKB:P78358

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UniProtKB:P78358

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UniProtKB:P78358

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UniProtKB:P78358

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Ovarian cancer stage IV


subject: UNII:5TAA004E22

object_name: stage IIIC primary peritoneal cavity cancer


subject: UNII:5TAA004E22

object_name: stage IIIA primary peritoneal cavity cancer


subject: UNII:5TAA004E22

object_name: stage IIIB primary peritoneal cavity cancer


subject: UNII:5TAA004E22

object_name: stage IIA primary peritoneal cavity cancer


subject: UNII:5TAA004E22

object_name: stage IIB primary peritoneal cavity cancer


subject: UNII:5TAA004E22

object_name: stage IV primary peritoneal cavity cancer


subject: UNII:5TAA004E22

object_name: FIGO Stage IIIC Ovarian Cancer


subject: UNII:5TAA004E22

object_name: Stage IIIC Ovarian Cancer


subject: UNII:5TAA004E22

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: FIGO Stage IIIA Ovarian Cancer


subject: UNII:5TAA004E22

object_name: stage IIIB ovarian epithelial cancer


subject: UNII:5TAA004E22

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: recurrent primary peritoneal cavity cancer


subject: UNII:5TAA004E22

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: stage IIB ovarian epithelial cancer


subject: UNII:5TAA004E22

object_name: stage IIA ovarian epithelial cancer


subject: UNII:5TAA004E22

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UNII:5TAA004E22

object_name: Recurrent ovarian cancer


subject: UNII:5TAA004E22

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Recurrent Fallopian Tube Carcinoma


subject: PR:000005931

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PR:000005931

object_name: Ovarian cancer stage IV


subject: PR:000005931

object_name: stage IIIC primary peritoneal cavity cancer


subject: PR:000005931

object_name: stage IIIA primary peritoneal cavity cancer


subject: PR:000005931

object_name: stage IIIB primary peritoneal cavity cancer


subject: PR:000005931

object_name: stage IIA primary peritoneal cavity cancer


subject: PR:000005931

object_name: stage IIB primary peritoneal cavity cancer


subject: PR:000005931

object_name: stage IV primary peritoneal cavity cancer


subject: PR:000005931

object_name: FIGO Stage IIIC Ovarian Cancer


subject: PR:000005931

object_name: Stage IIIC Ovarian Cancer


subject: PR:000005931

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: PR:000005931

object_name: FIGO Stage IIIA Ovarian Cancer


subject: PR:000005931

object_name: stage IIIB ovarian epithelial cancer


subject: PR:000005931

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: PR:000005931

object_name: recurrent primary peritoneal cavity cancer


subject: PR:000005931

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: PR:000005931

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: PR:000005931

object_name: stage IIB ovarian epithelial cancer


subject: PR:000005931

object_name: stage IIA ovarian epithelial cancer


subject: PR:000005931

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: PR:000005931

object_name: Recurrent ovarian cancer


subject: PR:000005931

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: PR:000005931

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: PR:000005931

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: PR:000005931

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: PR:000005931

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: PR:000005931

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: PR:000005931

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: PR:000005931

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: PR:000005931

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Ovarian cancer stage IV


subject: CHEBI:9168

object_name: stage IIIC primary peritoneal cavity cancer


subject: CHEBI:9168

object_name: stage IIIA primary peritoneal cavity cancer


subject: CHEBI:9168

object_name: stage IIIB primary peritoneal cavity cancer


subject: CHEBI:9168

object_name: stage IIA primary peritoneal cavity cancer


subject: CHEBI:9168

object_name: stage IIB primary peritoneal cavity cancer


subject: CHEBI:9168

object_name: stage IV primary peritoneal cavity cancer


subject: CHEBI:9168

object_name: FIGO Stage IIIC Ovarian Cancer


subject: CHEBI:9168

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:9168

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: FIGO Stage IIIA Ovarian Cancer


subject: CHEBI:9168

object_name: stage IIIB ovarian epithelial cancer


subject: CHEBI:9168

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: recurrent primary peritoneal cavity cancer


subject: CHEBI:9168

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: stage IIB ovarian epithelial cancer


subject: CHEBI:9168

object_name: stage IIA ovarian epithelial cancer


subject: CHEBI:9168

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:9168

object_name: Recurrent ovarian cancer


subject: CHEBI:9168

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:9168

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:KJ9D084FO4

object_name: rheumatoid arthritis


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: mild neurocognitive disorder


subject: CHEBI:8874

object_name: mild cognitive impairment


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: schizophrenia


subject: CHEBI:32682

subject_name: L-argininium

object_name: myocardial infarction


subject: CHEBI:32682

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:32682

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: PUBCHEM.COMPOUND:46874763

object_name: ventilator-associated pneumonia


subject: UMLS:C0003232

subject_name: Antibiotics


subject: CHEBI:94573

subject_name: Zibotentan

object_name: prostate carcinoma


subject: CHEBI:94573

object_name: prostate cancer


subject: UMLS:C4727050

object_name: glioma


subject: UMLS:C4727050

object_name: malignant glioma


subject: UMLS:C4727050

object_name: IDH gene mutation


subject: CHEBI:2453

subject_name: Acyclovir

object_name: viral meningitis


subject: CHEBI:2453

object_name: Herpes simplex type 2 infection


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UNII:6K6L7E3F1L

subject_name: Gefapixant

object_name: osteoarthritis, knee


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:75045

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:75045

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: GTOPDB:10140

subject_name: spartalizumab


subject: GTOPDB:10140


subject: GTOPDB:10140


subject: UNII:QOG25L6Z8Z


subject: UNII:QOG25L6Z8Z


subject: UNII:QOG25L6Z8Z


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Non-small cell lung cancer stage IIIB


subject: PUBCHEM.COMPOUND:131769963

object_name: Non-small cell lung cancer recurrent


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: UMLS:C1744376

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C1744376


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: cold agglutinin disease


subject: UNII:A3ULP0F556

object_name: autoimmune hemolytic anemia, cold type


subject: UMLS:C5556693

subject_name: Anti-CD226 Agonist Antibody LY3435151

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556693

object_name: Adult Solid Neoplasm


subject: UMLS:C5556693

object_name: Solid Neoplasm


subject: UMLS:C5556693

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5556693

object_name: undifferentiated pleomorphic sarcoma


subject: UMLS:C5556693

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: UMLS:C5556693

object_name: triple-negative breast carcinoma


subject: UMLS:C5556693

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5556693

object_name: liver carcinoma


subject: UMLS:C5556693

object_name: gastric adenocarcinoma


subject: UMLS:C5556693

object_name: suppressor of tumorigenicity 3


subject: UMLS:C5556693

object_name: cervical carcinoma


subject: UMLS:C5556693

object_name: leiomyosarcoma


subject: UMLS:C5556693

object_name: Childhood Leiomyosarcoma


subject: UMLS:C5556693

object_name: Adult Leiomyosarcoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C5207037

subject_name: Bifico

object_name: bipolar disorder


subject: UMLS:C5207037

object_name: schizophrenia


subject: MESH:D004043

subject_name: Dietary Fiber


subject: MESH:D004043


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Headache


subject: CHEBI:2666

object_name: Headache, CTCAE


subject: CHEBI:2666

object_name: migraine


subject: CHEBI:2666

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:2666

object_name: migraine with aura


subject: CHEBI:2666

object_name: Transformed migraine


subject: CHEBI:2666

object_name: Common Migraine


subject: CHEBI:2666

object_name: headache disorder


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Pregnancy in Diabetics


subject: CHEBI:5801

object_name: gestational diabetes


subject: PUBCHEM.COMPOUND:3367

object_name: myelofibrosis


subject: CHEBI:9570

subject_name: Thiotepa


subject: UMLS:C1614968

subject_name: Sativex

object_name: multiple sclerosis


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic leiomyosarcoma


subject: CHEBI:231679

object_name: Unresectable Leiomyosarcoma


subject: CHEBI:231679

object_name: leiomyosarcoma of the corpus uteri


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: heart failure


subject: CHEBI:85974

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: skin melanoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C4547390

subject_name: Vigil vaccine

object_name: colon carcinoma


subject: UMLS:C4547390

object_name: colorectal cancer


subject: UMLS:C4547390

object_name: colon cancer


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: peripheral vascular disease


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: UMLS:C5238362

subject_name: EGFR/HER2 Inhibitor DZD9008

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5238362

object_name: B-cell neoplasm


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)


subject: CHEBI:60648

object_name: Malignant neoplasms of thyroid and other endocrine glands (C73-C75)


subject: CHEBI:60648

object_name: malignant neoplasm of respiratory and intrathoracic organ


subject: CHEBI:60648

object_name: Malignant neoplasm of connective tissue


subject: CHEBI:60648

object_name: Malignant neoplasms of ill-defined, secondary and unspecified sites


subject: CHEBI:60648

object_name: Malignant melanoma of skin of breast


subject: CHEBI:60648

object_name: breast cancer


subject: CHEBI:60648

object_name: Malignant neoplasm of lip, oral cavity and pharynx


subject: CHEBI:60648

object_name: Primary malignant neoplasm of independent multiple sites


subject: CHEBI:60648

object_name: male reproductive organ cancer


subject: CHEBI:60648

object_name: Malignant neoplasm of female genital organs


subject: CHEBI:60648

object_name: malignant urinary system neoplasm


subject: CHEBI:60648

object_name: Malignant tumor of digestive organ


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C5238481

subject_name: HPV E6/E7-encoding Arenavirus Vaccine HB-201

object_name: human papillomavirus-related squamous cell carcinoma


subject: UNII:4B96SSC9KJ


subject: UNII:O4E1IFK37Y


subject: UMLS:C5417958

subject_name: HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202


subject: CHEBI:9123

subject_name: Sertraline

object_name: endogenous depression


subject: CHEBI:64816

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:64816

object_name: diffuse midline glioma


subject: CHEBI:64816

object_name: childhood brain stem glioma


subject: CHEBI:64816

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:64816

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:64816

object_name: anaplastic astrocytoma


subject: CHEBI:64816

object_name: Bilateral Thalamic Glioma


subject: CHEBI:64816

object_name: Childhood Gliomatosis Cerebri


subject: CHEBI:64816

object_name: gliomatosis cerebri


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Premature rupture of membranes


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: Glabellar frown lines


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: splenic marginal zone lymphoma


subject: PR:000005896

object_name: mild neurocognitive disorder


subject: PR:000005896

object_name: mild cognitive impairment


subject: PR:000005896

object_name: amnesia


subject: PR:000005896

object_name: Memory Impairment, CTCAE 5.0


subject: PR:000010140

subject_name: mitogen-activated protein kinase kinase kinase 8


subject: PR:000010140


subject: PR:000010140


subject: PR:000010140


subject: CHEBI:85182

subject_name: Dasabuvir

object_name: acute hepatitis C virus infection


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir


subject: PUBCHEM.COMPOUND:76668718

subject_name: Pibrentasvir


subject: CHEBI:85188

subject_name: paritaprevir


subject: CHEBI:45409

subject_name: Ritonavir


subject: PUBCHEM.COMPOUND:76192587

subject_name: Ombitasvir


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Epistaxis


subject: UNII:ZL1R02VT79

object_name: hereditary hemorrhagic telangiectasia


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Locally Advanced Renal Cell Carcinoma


subject: CHEBI:41423

subject_name: Celecoxib

object_name: myeloproliferative neoplasm


subject: CHEBI:41423

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:131174

subject_name: Navitoclax


subject: CHEBI:131174


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: UMLS:C3713905

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C3713905

object_name: COPD, severe early onset


subject: CHEBI:177705

subject_name: Birinapant

object_name: Locally Recurrent Head and Neck Squamous Cell Carcinoma


subject: CHEBI:177705

object_name: nasal cavity and paranasal sinus squamous cell carcinoma


subject: CHEBI:177705

object_name: non-keratinizing sinonasal squamous cell carcinoma


subject: CHEBI:177705

object_name: nasopharyngeal squamous cell carcinoma


subject: CHEBI:177705

object_name: Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: CHEBI:41423


subject: CHEBI:41423

object_name: SARS-CoV-2 acute respiratory disease


subject: CHEBI:4975

subject_name: Famotidine


subject: CHEBI:4975


subject: CHEBI:31348

subject_name: Capecitabine

object_name: rectum adenocarcinoma


subject: PUBCHEM.COMPOUND:139600317

object_name: grade II glioma


subject: UMLS:C5700409


subject: UMLS:C5555581

subject_name: Inetetamab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C5555581

object_name: Carcinoma breast stage IV


subject: UMLS:C5555581

object_name: malignant neoplasm of breast stage IV


subject: UMLS:C1831824

object_name: non-small cell lung carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: differentiated thyroid carcinoma


subject: CHEBI:85994

object_name: thyroid gland follicular carcinoma


subject: CHEBI:85994

object_name: thyroid gland papillary carcinoma


subject: UNII:F40IRN5981

subject_name: Chiauranib

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:F40IRN5981

object_name: Adult Soft Tissue Sarcoma


subject: UNII:F40IRN5981

object_name: sarcoma


subject: UNII:F40IRN5981

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:F40IRN5981

object_name: soft tissue sarcoma


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: celiac disease


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: Stage II Colon Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage II Colon Cancer AJCC v7


subject: UMLS:C1882421

object_name: Stage II Colon Cancer


subject: UMLS:C1882421

object_name: Carcinoma of colon, stage I


subject: UMLS:C1882421

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: UMLS:C1882421

object_name: Stage I Colon Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C1882421

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage III Colon Cancer


subject: UMLS:C1882421

object_name: colon adenocarcinoma


subject: UNII:4B3SC438HI

subject_name: METHYLPHENIDATE HYDROCHLORIDE

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:4B3SC438HI


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: anemia


subject: PUBCHEM.COMPOUND:126456119

object_name: Anemia, CTCAE


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: GTOPDB:13611

subject_name: patisiran

object_name: polyneuropathy


subject: GTOPDB:13611

object_name: wild type ATTR amyloidosis


subject: GTOPDB:13611

object_name: amyloidosis, hereditary systemic 1


subject: GTOPDB:13611

object_name: familial amyloid neuropathy


subject: GTOPDB:13611

object_name: ATTR Amyloidosis


subject: GTOPDB:13611

object_name: Cardiac amyloidosis


subject: UNII:50FKX8CB2Y

subject_name: Patisiran


subject: UNII:50FKX8CB2Y


subject: UNII:50FKX8CB2Y


subject: UNII:50FKX8CB2Y


subject: UNII:50FKX8CB2Y


subject: UNII:50FKX8CB2Y


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Post-Operative Pain


subject: UMLS:C1440044

subject_name: A,B


subject: UMLS:C5421218

subject_name: Anti-SARS-CoV-2 equine immunoglobulin fragments


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:114785

object_name: Non-small cell lung cancer stage II